AbCellera Biologics, Inc. (ABCL)
5.20
+0.06
(+1.17%)
USD |
NASDAQ |
May 22, 16:00
5.26
+0.06
(+1.15%)
After-Hours: 20:00
AbCellera Biologics Total Assets (Quarterly) : 1.307B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tempus AI, Inc. | 2.135B |
| Standard BioTools, Inc. | 639.11M |
| Cytek Biosciences, Inc. | 449.11M |
| Agilent Technologies, Inc. | 12.81B |
| Inotiv, Inc. | 702.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 192.92M |
| Shareholders Equity (Quarterly) | 938.08M |
| Debt to Equity Ratio | 0.1494 |
| Current Ratio | 14.05 |
| Net Debt Paydown Yield | -1.41% |